Allied Market Research has published a comprehensive new study titled "Non-Animal Alternative Testing Market by Technology ...

The core principle of BETMAT’s Kinetic Chromogenic LAL Assay is based on the specific enzymatic cascade triggered by the interaction between Limulus Amebocyte Lysate (LAL) and bacterial ...

SGS, the world’s leading testing, inspection and certification company, has expanded its analytical capabilities for the Chinese pharmaceutical industry with the introduction of nuclear magnetic ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

The MarketWatch News Department was not involved in the creation of this content. Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform CAMBRIDGE, U.K.

Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River Laboratories International, Inc. (Charles River), a leading global drug ...

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Germany, says it has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra™ CHO genetic ...

As a central pillar of modern society, the pharmaceutical industry bears the load of billions of lives around the world. In 2022, the global revenue of the pharmaceutical industry approximated $1.5 ...

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the ...

Merck KGaA's subsidiary MilliporeSigma has developed a first-of-its-kind “all-in-one” CHO genetic stability assay, according to an April 16 release. The company claims that the platform, called ...

Seoul National University College of Engineering announced that a research team led by Professor Sunghoon Kwon from the Department of Electrical and Computer Engineering, in collaboration with ...